Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

上海醫藥集團股份有限公司

Shanghai Pharmaceuticals Holding Co., Ltd.*

(A joint stock company incorporated in the People's Republic of China with limited liability)

(Stock Code: 02607) NOTICE OF BOARD MEETING

The board of directors (the "Board") of Shanghai Pharmaceuticals Holding Co., Ltd. (the "Company") hereby announces that a meeting of the Board will be held on Monday, 28 August 2017 for the purpose of, among other matters, approving the interim results of the Company and its subsidiaries for the six months ended 30 June 2017 and its publication.

By order of the Board

Shanghai Pharmaceuticals Holding Co., Ltd.* ZHOU Jun

Chairman

Shanghai, the PRC, 11 August 2017

As of the date of this announcement, the executive Directors of the Company are Mr. CHO Man, Mr. LI Yongzhong and Mr. SHEN Bo; the non-executive Directors are Mr. ZHOU Jun and Ms. LI An; and the Independent Non-executive Directors are Mr. WAN Kam To, Mr. TSE Cho Che, Edward, Mr. CAI Jiangnan and Mr. HONG Liang.

* For identification purpose only

Shanghai Pharmaceuticals Holding Co. Ltd. published this content on 11 August 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 11 August 2017 12:46:04 UTC.

Original documenthttp://english.sphchina.com/art/2017/8/11/art_215_6685.html

Public permalinkhttp://www.publicnow.com/view/6729C2C6D7BC3DF7BCD8EFF5A3B45350E34DA3F3